Australia’s CSL has opened the first phase of a $170 million plasma products plant that will boost production for the U.S. and Europe as well as Asia-Pacific markets. CSL today said the new facility ...
Nearly 15 per cent of CSL’s global workforce will be reduced in the biggest shake-up of the company in decades aimed at “simplifying the business”. CSL employs about 30,000 staff globally. Its share ...
Australia's largest pharmaceutical company will cut 3000 jobs globally, with $20bn wiped from the company’s market value. Nearly 15 per cent of CSL’s global workforce will be reduced in the biggest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results